{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T18:59:59Z","timestamp":1770577199198,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bone.2019.03.010","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T21:27:06Z","timestamp":1552080426000},"page":"28-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormone"],"prefix":"10.1016","volume":"123","author":[{"given":"Subhashis","family":"Pal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konica","family":"Porwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj Kumar","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Yaseen","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamunur","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. John","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Wahajuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkitanarayanan","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayesh R.","family":"Bellare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2473-0246","authenticated-orcid":false,"given":"Naibedya","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2019.03.010_bb0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-med-070313-022841","article-title":"Management of postmenopausal osteoporosis","volume":"66","author":"Andreopoulou","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bone.2019.03.010_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1874312900802010058","article-title":"Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65\u202fyears of age in a primary care setting in Spain: a questionnaire","volume":"2","author":"Luz Rentero","year":"2008","journal-title":"Open Rheumatol J"},{"issue":"2","key":"10.1016\/j.bone.2019.03.010_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/13543784.2015.973021","article-title":"Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis","volume":"24","author":"Polyzos","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.bone.2019.03.010_bb0020","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00198-016-3886-y","article-title":"Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2\u202fyears","volume":"28","author":"Modi","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2019.03.010_bb0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1586\/14737140.2016.1159515","article-title":"Medication adherence to oral anticancer drugs: systematic review","volume":"16","author":"Huang","year":"2016","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.bone.2019.03.010_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"25","key":"10.1016\/j.bone.2019.03.010_bb0035","doi-asserted-by":"crossref","first-page":"22191","DOI":"10.1074\/jbc.M110364200","article-title":"New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP","volume":"277","author":"Fujita","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bone.2019.03.010_bb0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0169-6009(08)80105-5","article-title":"Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture","volume":"23","author":"Moore","year":"1993","journal-title":"Bone Miner"},{"issue":"6","key":"10.1016\/j.bone.2019.03.010_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.070302","article-title":"Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats","volume":"22","author":"Sampath","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2019.03.010_bb0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3349\/ymj.2005.46.1.149","article-title":"Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts","volume":"46","author":"Cho","year":"2005","journal-title":"Yonsei Med. J."},{"issue":"1","key":"10.1016\/j.bone.2019.03.010_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000365","article-title":"Pentoxifylline for vascular health: a brief review of the literature","volume":"3","author":"McCarty","year":"2016","journal-title":"Open Heart"},{"issue":"6","key":"10.1016\/j.bone.2019.03.010_bb0060","first-page":"676","article-title":"Effect of pentoxifylline on healing of segmental bone defects and angiogenesis","volume":"49","author":"Cakmak","year":"2015","journal-title":"Acta Orthop. Traumatol. Turc."},{"issue":"1","key":"10.1016\/j.bone.2019.03.010_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5625\/lar.2017.33.1.15","article-title":"The effects of pentoxifylline adminstration on fracture healing in a postmenopausal osteoporotic rat model","volume":"33","author":"Vashghani Farahani","year":"2017","journal-title":"Lab Anim Res"},{"issue":"6","key":"10.1016\/j.bone.2019.03.010_bb0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S8756-3282(00)00395-1","article-title":"Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice","volume":"27","author":"Kinoshita","year":"2000","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2019.03.010_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/1755-5922.12076","article-title":"Pentoxifylline in heart failure: a meta-analysis of clinical trials","volume":"32","author":"Champion","year":"2014","journal-title":"Cardiovasc. Ther."},{"issue":"3","key":"10.1016\/j.bone.2019.03.010_bb0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/17453674.2010.483986","article-title":"Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid","volume":"81","author":"Baofeng","year":"2010","journal-title":"Acta Orthop."},{"issue":"4 Pt 1","key":"10.1016\/j.bone.2019.03.010_bb0085","first-page":"E416","article-title":"Effect of sex steroids on peak bone density of growing rabbits","volume":"255","author":"Gilsanz","year":"1988","journal-title":"Am. J. Phys."},{"issue":"1","key":"10.1016\/j.bone.2019.03.010_bb0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00256-005-0022-z","article-title":"Bone mineral measurements of subchondral and trabecular bone in healthy and osteoporotic rabbits","volume":"35","author":"Castaneda","year":"2006","journal-title":"Skelet. Radiol."},{"issue":"3","key":"10.1016\/j.bone.2019.03.010_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jbmr.2719","article-title":"Odanacatib restores trabecular bone of skeletally mature female rabbits with osteopenia but induces brittleness of cortical bone: a comparative study of the investigational drug with PTH, estrogen, and alendronate","volume":"31","author":"Khan","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2019.03.010_bb0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.taap.2016.02.002","article-title":"Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats","volume":"295","author":"Pal","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.bone.2019.03.010_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0011-393X(03)00018-3","article-title":"Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease","volume":"64","author":"Best","year":"2003","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6","key":"10.1016\/j.bone.2019.03.010_bb0110","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2165\/00002512-199507060-00007","article-title":"Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders","volume":"7","author":"Frampton","year":"1995","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.bone.2019.03.010_bb0115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jpha.2014.09.001","article-title":"Quantification of tolvaptan in rabbit plasma by LC-MS\/MS: application to a pharmacokinetic study","volume":"5","author":"Moola","year":"2015","journal-title":"J Pharm Anal"},{"issue":"7","key":"10.1016\/j.bone.2019.03.010_bb0120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bone.2019.03.010_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biomaterials.2015.03.046","article-title":"Variants of self-assembling peptide, KLD-12 that show both rapid fracture healing and antimicrobial properties","volume":"56","author":"Tripathi","year":"2015","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bone.2019.03.010_bb0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jbmr.223","article-title":"Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits","volume":"26","author":"Pennypacker","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2019.03.010_bb0135","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S8756-3282(02)00874-8","article-title":"Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats","volume":"31","author":"Hara","year":"2002","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bone.2019.03.010_bb0140","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/mnfr.201200200","article-title":"[6]-Gingerol induces bone loss in ovary intact adult mice and augments osteoclast function via the transient receptor potential vanilloid 1 channel","volume":"56","author":"Khan","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"issue":"4","key":"10.1016\/j.bone.2019.03.010_bb0145","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S8756-3282(98)00112-4","article-title":"Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies","volume":"23","author":"Roschger","year":"1998","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2019.03.010_bb0150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jc.2007-1876","article-title":"Bone mineral density changes during the menopause transition in a multiethnic cohort of women","volume":"93","author":"Finkelstein","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2019.03.010_bb0155","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/17425247.2.6.993","article-title":"Delivery of parathyroid hormone for the treatment of osteoporosis","volume":"2","author":"Morley","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"10.1016\/j.bone.2019.03.010_bb0160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2009.09.028","article-title":"An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation","volume":"46","author":"Kumar","year":"2010","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2019.03.010_bb0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00198-015-3392-7","article-title":"A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates","volume":"27","author":"Cosman","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"4 Pt 2","key":"10.1016\/j.bone.2019.03.010_bb0170","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0091-6749(86)90052-7","article-title":"Dose-dependent kinetics of theophylline","volume":"78","author":"Lesko","year":"1986","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.bone.2019.03.010_bb0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40279-013-0100-7","article-title":"Bone quality: the determinants of bone strength and fragility","volume":"44","author":"Fonseca","year":"2014","journal-title":"Sports Med."},{"issue":"6","key":"10.1016\/j.bone.2019.03.010_bb0180","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/17453670903350032","article-title":"Parathyroid hormone PTH(1-34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits","volume":"80","author":"Aleksyniene","year":"2009","journal-title":"Acta Orthop."},{"issue":"4","key":"10.1016\/j.bone.2019.03.010_bb0185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1359\/jbmr.2003.18.4.769","article-title":"Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18\u202fmonths","volume":"18","author":"Paschalis","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2019.03.010_bb0190","first-page":"33","article-title":"Anabolic actions of PTH in the skeletons of animals","volume":"2","author":"Hock","year":"2001","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"8","key":"10.1016\/j.bone.2019.03.010_bb0195","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1210\/jc.2008-2630","article-title":"Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis","volume":"94","author":"Leder","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2019.03.010_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.embor.7400627","article-title":"cGMP signalling: from bench to bedside. Conference on cGMP generators, effectors and therapeutic implications","volume":"7","author":"Feil","year":"2006","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.bone.2019.03.010_bb0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000137435","article-title":"Effects of synthetic parathyroid hormone on vascular beds of dogs","volume":"21","author":"Pang","year":"1980","journal-title":"Pharmacology"},{"issue":"3\u20134","key":"10.1016\/j.bone.2019.03.010_bb0210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(84)90452-7","article-title":"Effects of synthetic parathyroid hormone on hemodynamics and regional blood flows","volume":"97","author":"Wang","year":"1984","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bone.2019.03.010_bb0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.medengphy.2011.06.010","article-title":"Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits","volume":"34","author":"Liu","year":"2012","journal-title":"Med. Eng. Phys."},{"issue":"4","key":"10.1016\/j.bone.2019.03.010_bb0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF01623240","article-title":"Effects of glucocorticoids on skeletal growth in rabbits evaluated by dual-photon absorptiometry, microscopic connectivity and vertebral compressive strength","volume":"4","author":"Grardel","year":"1994","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.bone.2019.03.010_bb0225","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/s11999-010-1751-4","article-title":"Infrared assessment of bone quality: a review","volume":"469","author":"Paschalis","year":"2011","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2019.03.010_bb0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bone.2019.03.010_bb0235","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The drug repurposing hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219300869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:42:47Z","timestamp":1757612567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219300869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":47,"alternative-id":["S8756328219300869"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.03.010","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormone","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}